The focus of management of ovarian cancer should be minimisation of the physical and psychosocial impact of the cancer and its treatment. The surgical approach is the cornerstone of all management of ovarian cancers.
The Clinical practice guidelines for the management of women with epithelial ovarian cancer and associated resources are designed to assist in decision making by women and their doctors.
Clinical practice guidelines
- Clinical practice guidelines for the management of women with epithelial ovarian cancer
Publication date: July 2004 - Clinical practice guidelines for management of women at high risk of ovarian cancer
Publication date: October 2011
GP resources
- Appropriate referral of women with suspected ovarian cancer
Publication date: 2009
Provides information to assist clinicians identify those women who should be referred to a gynaecological oncologist and includes a risk of malignancy index. - Assessment of symptoms that may be ovarian cancer
Publication date: 2005
Intended to assist general practitioners assess whether a woman with persistent, unexplained symptoms may have ovarian cancer.
Other information on this topic
- Evidence review – Neoadjuvant chemotherapy in ovarian cancer: a systematic review (Publication date: April 2008)
- Evidence review – The use of intraperitoneal chemotherapy for ovarian cancer (Publication date: 2006)
In January 2006 the National Cancer Institute (NCI) USA published a clinical announcement to clarify the role of intraperitoneal chemotherapy for ovarian cancer, based on a systematic review of randomised controlled trials. This summary developed by National Breast Cancer Centre** includes evidence available to Oct 2006. New data are constantly emerging. The conclusions of this summary are likely to change with longer follow-up periods and in light of evidence from other trials. View full NCI report.
The Use Of Intraperitoneal Chemotherapy For Ovarian Cancer - a summary of findings developed by the National Breast Cancer Centre**
** In February 2008, National Breast Cancer Centre (NBCC), incorporating the Ovarian Cancer Program, changed its name to National Breast and Ovarian Cancer Centre (NBOCC). In July 2011, NBOCC amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.